Metrics
106 Record Views
Journal article
Prediction of Vancomycin dose for recommended trough concentrations in pediatric patients with cystic fibrosis
The Journal of Clinical Pharmacology, Vol.58, pp.662-665
58
2018
PMID: 29319843
Web of Science ID: WOS:000430471600010
Abstract
Vancomycin is a key antibiotic used in the treatment of multiple conditions including infections associated with cystic fibrosis and methicillin-resistant Staphylococcus aureus. The present study sought to develop a model based on empirical evidence of optimal vancomycin dose as judged by clinical observations that could accelerate the achievement of desired trough level in children with cystic fibrosis. Transformations of dose and trough were used to arrive at regression models with excellent fit for dose based on weight or age for a target trough. Results of this study indicate that the 2 proposed regression models are robust to changes in age or weight, suggesting that the daily dose on a per-kilogram basis is determined primarily by the desired trough level. The results show that to obtain a vancomycin trough level of 20 μg/mL, a dose of 80 mg/kg/day is needed. This analysis should improve the efficiency of vancomycin usage by reducing the number of titration steps, resulting in improved patient outcome and experience.
Related links
Details
- Title
- Prediction of Vancomycin dose for recommended trough concentrations in pediatric patients with cystic fibrosis
- Publication Details
- The Journal of Clinical Pharmacology, Vol.58, pp.662-665
- Resource Type
- Journal article
- Publisher
- Wiley-Blackwell Publishing, Inc.; United States
- Series
- 58
- Copyright
- 2018, The American College of Clinical Pharmacology
- Identifiers
- WOS:000430471600010; 99380090301406600
- Academic Unit
- Mathematics and Statistics; Hal Marcus College of Science and Engineering ; Biology
- Language
- English